Companies are challenged to drive internal efficiencies, do more with less waste, in a more sustainable way with greater resiliency from challenged supply lines.
While these threats have translated to mismatched supply/demand and greater price inflation, solving these operational problems can help deliver on a rare combination of reduced operating costs, sustained margins, and greater affordability to the customer– while also maintaining quality of service and product.
PwC works across industry and sector, bringing professionals with deep industry-leading knowledge to help develop sound operating strategies and translate those strategies into executable plans that can also help deliver the desired outcomes. PwC does not stop at operational strategy. We can help you create a targeted strategy and business case and then work with you through delivery and outcome realization.
In recent years, consumer companies’ supply chains have been tested more than any other time in history. With inflation, rising raw material prices, and changing consumer sentiment, companies often have to be resilient and build plans so they can retain customers and maintain margin. PwC focuses on helping you build the right strategies to improve your efficiency and effectiveness across end-to-end operations and help deliver both short and long-term value creation.
The shift is on to a more sustainable and resilient future. Operationally, PwC focuses on helping improve field operations, increasing infrastructure and assets, and helping gain better capital and operational execution. We help execute transformations to switch capital and operational spend to invest in renewable infrastructure. As a key area of focus, we can help you improve the efficiency and reliability of the operational networks that deliver electricity, energy, and gas to the end customer. In addition, our team can help you improve safety, reliability, and uptime of assets and equipment and also help drive improvements to per unit operating margin.
5G technology has arrived, and just in time. As a result of COVID-19, the world seems to continue having an insatiable appetite for high bandwidth services. We can work with clients to help get value out of their current assets and estimate, plan, and deliver on the rollout of new technology when the market is right for it.
Pharmaceutical and medical device technologies and operations are rapidly changing. Over the last decade, pharmaceuticals has evolved with new breakthrough drug classes including mRNA, cell and gene therapy and therapeutic approaches like microbiome, personalized medicine and digital health. Medical devices have also transformed with new innovations and opportunities in digitally enabled, connected products services such as smart devices and implants, surgery and materials and manufacturing technologies. At the same time, both pharmaceutical and medical device companies continue to face challenges from pricing pressure, supply chain disruption and uncertainty, rising costs and regulatory changes.
PLS operations strategy can help pharmaceutical and medical device companies develop and execute effective strategies to evolve, drive growth, and improve performance, while helping boost their operations, business models, and investments for competitive advantage and sustained growth. Our key focus areas include:
Companies that deliver commodities or consume them in their manufacturing operations typically have a market-driven mandate to keep the cost of services and products affordable. In short, nearly every company needs an executable hedging and portfolio strategy to deliver on this mandate while helping maintain an increasing margin. PwC’s team of professionals can help you develop these strategies, taking into account sustainable initiatives, and deliver them through improved technology and business operations. We help execute strategies across industry and sector through a deep understanding of the power, energy, metals, and agricultural markets.